ACHE and Alzheimer disease: Selective inhibition of AChE is crucial for developing safe anti-AD molecules, due to the possibility of cholinergic distress caused by BuChE’s inhibition, making molecule 15 a safe candidate (BuChE; IC50 > 100 μM).